close
This ad will auto close in 10 seconds
Tech Mahindra becomes 3rd entity to quit payments bank plan; cites margin concerns

Tech Mahindra becomes 3rd entity to quit payments bank plan; cites margin concerns

Tech Mahindra is the third applicant to abandon the plan to set up payments bank after Cholamandalam which quit last month and Dilip Shanghvi-IDFC Bank-Telenor combine last Friday.

Know the business stalwarts who were given Padma award this year

Know the business stalwarts who were given Padma award this year

A host of leaders from the business world have recieved Padma awards this year. Check out the list.

Sun Pharma Q3 net profit surges over 3-fold to Rs 1,417 crore

Sun Pharma Q3 net profit surges over 3-fold to Rs 1,417 crore

Sun Pharmaceutical Industries on Friday posted an over three-fold jump in its consolidated net profit at Rs 1,416.60 crore for the December quarter, driven by robust sales in domestic as well as international markets.

Mukesh Ambani, Azim Premji, Dilip Shanghvi among world's 50 wealthiest people

Mukesh Ambani, Azim Premji, Dilip Shanghvi among world's 50 wealthiest people

Three Indians - Mukesh Ambani, Azim Premji and Dilip Shanghvi - have made it to a global list of 50 wealthiest people that is topped by Bill Gates.

 

India's busines tycoons named for Padma Awards

India's busines tycoons named for Padma Awards

Business tycoon late Dhirubhai Ambani and construction magnate Pallonji Shapoorji Mistry are among industrialists chosen for this year's highest civilian awards that recognise the country's best talents.

Dilip Shanghvi, promoters to make open offer to buy 26% Suzlon stake

Dilip Shanghvi, promoters to make open offer to buy 26% Suzlon stake

The offer, that would begin on December 28 and close on January 8, 2016, comes after Shanghvi decided to acquire 23 percent stake in Suzlon with an equity investment of Rs 1,800 crore. The deal was announced earlier this year.

India's Top 10 Richest People in 2015

Mukesh Ambani has retained the tag as India’s richest for the ninth year in a row with a net worth of USD 18.9 billion even as declining macroeconomic barometers flattened the fortunes of the country’s uber-rich.

Sun Pharma Q2 net profit dips 46% to Rs 1,107 crore

Sun Pharma Q2 net profit dips 46% to Rs 1,107 crore

Drug major Sun Pharmaceutical Industries on Saturday reported 46.02 percent dip in its consolidated net profit at Rs 1,106.66 crore for the second quarter ended September 30, 2015 on account of lower sales, volatile currency movements and supply constraints.

Ranbaxy integration: Sun may drop some non-strategic units

Ranbaxy integration: Sun may drop some non-strategic units

Sun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories, which it acquired in a USD 4 billion deal last year.

'Indian pharma industry capable of discovering new drugs'

'Indian pharma industry capable of discovering new drugs'

Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today

Sun Pharma may file new drug application with USFDA: Shanghvi

Sun Pharma may file new drug application with USFDA: Shanghvi

India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.

Sun Pharma asks some Ranbaxy employees to leave, post merger

Sun Pharma asks some Ranbaxy employees to leave, post merger

Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its USD 4 billion acquisition of the Gurgaon-based firm.

Sun Pharma asks 18 top brass of Ranbaxy to resign

This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.

Open to acquisitions but selective with targets: Sun Pharma

"We continue to remain opportunistic for acquisition... We are not looking at buying businesses where we have to spend a lot of time in managing," Sun Pharma MD Dilip Shanghvi said in an analyst call.

CCI approves Shanghvi's deal with Suzlon

Competition Commission has cleared billionaire Dilip Shanghvi's proposed Rs 1,800-crore stake buy in wind turbine maker Suzlon Energy.

Mukesh Ambani regains richest Indian slot from Dilip Shanghvi

Industrialist Mukesh Ambani Monday regained his position as the world's richest Indian with a networth of USD 19.6 billion, as pharma tycoon Dilip Shanghvi slipped to the second place after remaining on the top for about seven weeks.

Sun Pharma, Ranbaxy rise after regulatory nods for merger deal

At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.

Ranbaxy merger: Sun Pharma readies new leadership team

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the organisations.

Ambani loses India rich list top spot to pharma tycoon

A fall in oil prices saw Mukesh Ambani cede his status as "India`s richest man" on Thursday to pharmaceutical tycoon Dilip Shanghvi, who edged to the top of Forbes` list of billionaires in the country.

Dilip Shanghvi overtakes Mukesh Ambani as richest Indian

Dilip Shanghvi overtakes Mukesh Ambani as richest Indian

Pharma tycoon Dilip Shanghvi Wednesday surpassed Mukesh Ambani as the world's richest Indian with a net worth of USD 21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.